scholarly journals Automatic Segmentation of Hippocampus and Classification of brain MRI for Alzheimer’s Detection

2021 ◽  
Vol 10 (3) ◽  
pp. 1743-1750
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Early Stage ◽  
Automatic Segmentation ◽  
Brain Mri ◽  
Standard Technique ◽  
Disease Diagnosis ◽  
Support Vector ◽  
Shape Feature

Hippocampus is the structure of brain thatis mostly affected by Alzheimer’s disease at an early stage. Atrophy of hippocampus has been found asa predictive feature for Alzheimer’s disease diagnosis. To measure the atrophy of hippocampus we need to segment it out from surrounding structures of brain. Manual segmentation of hippocampus has beenfound standard technique for hippocampus segmentation in literature, but isvery time consuming and depends on particular anatomical information. In this work we have proposed an automatic approach to segment hippocampus considering texture and active contour from the brain Magnetic Resonance Image. After segmentation, features based on atrophy and shape of hippocampus has beenmeasured. Support vector machine classifier with radial basis function kernel has been analyzed with extracted features for classification of Alzheimer’s and control subjects. In the proposed technique, 200AD MRI and 200control MRI have been considered from Alzheimer’s Disease Neuroimaging Initiative database. The experiment have shown 93% accuracy, 0.96 sensitivity and 0.90specificity with atrophy feature and 94% accuracy, 0.96sensitivity and 0.92specificity with shape feature. Further, 0.96sensitivity, 1 specificity and 98% accuracyhave beenobtained with the fusion of atrophy and shape feature

scholarly journals Diagnosis and Classification of Alzheimer's Disease by Using a Convolution Neural Network Algorithm

2021 ◽  
Author(s):  
Mosleh Hmoud Al-Adhaileh
Keyword(s):  
Neural Network ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Early Stage ◽  
Brain Mri ◽  
Brain Magnetic Resonance Imaging ◽  
Classification Systems ◽  
Detection Accuracy ◽  
Learning Approaches

Abstract Alzheimer's disease (AD) is a high-risk and atrophic neurological illness that slowly and gradually destroys brain cells (i.e. neurons). As the most common type of amentia, AD affects 60–65% of all people with amentia and poses major health dangers to middle-aged and elderly people. For classification of AD in the early stage, classification systems and computer-aided diagnostic techniques have been developed. Previously, machine learning approaches were applied to develop diagnostic systems by extracting features from neural images. Currently, deep learning approaches have been used in many real-time medical imaging applications. In this study, two deep neural network techniques, AlexNet and Restnet50, were applied for the classification and recognition of AD. The data used in this study to evaluate and test the proposed model included those from brain magnetic resonance imaging (MRI) images collected from the Kaggle website. A convolutional neural network (CNN) algorithm was applied to classify AD efficiently. CNNs were pre-trained using AlexNet and Restnet50 transfer learning models. The results of this experimentation showed that the proposed method is superior to the existing systems in terms of detection accuracy. The AlexNet model achieved outstanding performance based on five evaluation metrics (accuracy, F1 score, precision, sensitivity and specificity) for the brain MRI datasets. AlexNet displayed an accuracy of 94.53%, specificity of 98.21%, F1 score of 94.12% and sensitivity of 100%, outperforming Restnet50. The proposed method can help improve CAD methods for AD in medical investigations.

scholarly journals Support vector machine based alzheimer’s disease diagnosis using synchrony features

2020 ◽  
Vol 9 (1) ◽  
pp. 57
Author(s):  
Nilesh Kulkarni
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Support Vector Machine ◽  
Early Stage ◽  
Research Work ◽  
Normal Subjects ◽  
Disease Diagnosis ◽  
Support Vector ◽  
Experimental Database ◽  
Wavelet Features

Previous research work has highlighted that neuro-signals of Alzheimer’s disease patients are least complex and have low synchronization as compared to that of healthy and normal subjects. The changes in EEG signals of Alzheimer’s subjects start at early stage but are not clinically observed and detected. To detect these abnormalities, three synchrony measures and wavelet-based features have been computed and studied on experimental database. After computing these synchrony measures and wavelet features, it is observed that Phase Synchrony and Coherence based features are able to distinguish between Alzheimer’s disease patients and healthy subjects. Support Vector Machine classifier is used for classification giving 94% accuracy on experimental database used. Combining, these synchrony features and other such relevant features can yield a reliable system for diagnosing the Alzheimer’s disease.

A Comparative Study of Alzheimer Detection Techniques

2021 ◽  
Vol 9 (8) ◽  
pp. 2877-2883
Author(s):  
Adwait Patil
Keyword(s):  
Machine Learning ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Deep Learning ◽  
Comparative Study ◽  
Fuzzy System ◽  
Early Stage ◽  
Machine Learning Algorithms ◽  
Support Vector ◽  
Detection Techniques

Abstract: Alzheimer’s disease is one of the neurodegenerative disorders. It initially starts with innocuous symptoms but gradually becomes severe. This disease is so dangerous because there is no treatment, the disease is detected but typically at a later stage. So it is important to detect Alzheimer at an early stage to counter the disease and for a probable recovery for the patient. There are various approaches currently used to detect symptoms of Alzheimer’s disease (AD) at an early stage. The fuzzy system approach is not widely used as it heavily depends on expert knowledge but is quite efficient in detecting AD as it provides a mathematical foundation for interpreting the human cognitive processes. Another more accurate and widely accepted approach is the machine learning detection of AD stages which uses machine learning algorithms like Support Vector Machines (SVMs) , Decision Tree , Random Forests to detect the stage depending on the data provided. The final approach is the Deep Learning approach using multi-modal data that combines image , genetic data and patient data using deep models and then uses the concatenated data to detect the AD stage more efficiently; this method is obscure as it requires huge volumes of data. This paper elaborates on all the three approaches and provides a comparative study about them and which method is more efficient for AD detection. Keywords: Alzheimer’s Disease (AD), Fuzzy System , Machine Learning , Deep Learning , Multimodal data

scholarly journals Nonlinear Classification of EEG recordings from patients with Alzheimer’s Disease using Gaussian Process Latent Variable Model

2020 ◽  
Author(s):  
S. Rajintha. A. S. Gunawardena ◽  
Fei He ◽  
Ptolemaios Sarrigiannis ◽  
Daniel J. Blackburn
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Gaussian Process ◽  
Manifold Learning ◽  
Latent Variable ◽  
Time Window ◽  
Support Vector ◽  
Nonlinear Dimensionality Reduction ◽  
Variable Model

AbstractIn this work, nonlinear temporal features from multi-channel EEGs are used for the classification of Alzheimer’s disease patients from healthy individuals. This was achieved by temporal manifold learning using Gaussian Process Latent Variable Models (GPLVM) as a nonlinear dimensionality reduction technique. Classification of the extracted features was undertaken using a nonlinear Support Vector Machine. Comparisons were made against the linear counterpart, Principle Component Analysis while exploring the effect of the time window or EEG epoch length used. It was demonstrated that temporal manifold learning using GPLVM is better in extracting features that attain high separability and prediction accuracy. This work aims to set the significance of using GPLVM temporal manifold learning for EEG feature extraction in the classification of Alzheimer’s disease.

scholarly journals A Deep Siamese Convolution Neural Network for Multi-Class Classification of Alzheimer Disease

2020 ◽  
Vol 10 (2) ◽  
pp. 84 ◽  
Author(s):  
Atif Mehmood ◽  
Muazzam Maqsood ◽  
Muzaffar Bashir ◽  
Yang Shuyuan
Keyword(s):  
Neural Network ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Convolutional Neural Network ◽  
State Of The Art ◽  
Early Stage ◽  
The State ◽  
Test Accuracy ◽  
Learning Approaches

Alzheimer’s disease (AD) may cause damage to the memory cells permanently, which results in the form of dementia. The diagnosis of Alzheimer’s disease at an early stage is a problematic task for researchers. For this, machine learning and deep convolutional neural network (CNN) based approaches are readily available to solve various problems related to brain image data analysis. In clinical research, magnetic resonance imaging (MRI) is used to diagnose AD. For accurate classification of dementia stages, we need highly discriminative features obtained from MRI images. Recently advanced deep CNN-based models successfully proved their accuracy. However, due to a smaller number of image samples available in the datasets, there exist problems of over-fitting hindering the performance of deep learning approaches. In this research, we developed a Siamese convolutional neural network (SCNN) model inspired by VGG-16 (also called Oxford Net) to classify dementia stages. In our approach, we extend the insufficient and imbalanced data by using augmentation approaches. Experiments are performed on a publicly available dataset open access series of imaging studies (OASIS), by using the proposed approach, an excellent test accuracy of 99.05% is achieved for the classification of dementia stages. We compared our model with the state-of-the-art models and discovered that the proposed model outperformed the state-of-the-art models in terms of performance, efficiency, and accuracy.

scholarly journals Deep Learning in Brain MRI: Effect of Data Leakage Due to Slice-level Split Using 2D Convolutional Neural Networks

2021 ◽  
Author(s):  
Ekin Yagis ◽  
Selamawet Workalemahu Atnafu ◽  
Alba García Seco de Herrera ◽  
Chiara Marzi ◽  
Marco Giannelli ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Neural Networks ◽  
Alzheimer's Disease ◽  
Convolutional Neural Networks ◽  
De Novo ◽  
Neurological Diseases ◽  
Brain Mri ◽  
Progression Markers ◽  
Magnetic Resonance Imaging Mri

Abstract In recent years, 2D convolutional neural networks (CNNs) have been extensively used for the diagnosis of neurological diseases from magnetic resonance imaging (MRI) data due to their potential to discern subtle and intricate patterns. Despite the high performances reported in numerous studies, developing CNN models with good generalization abilities is still a challenging task due to possible data leakage introduced during cross-validation (CV). In this study, we quantitatively assessed the effect of a data leakage caused by 3D MRI data splitting based on a 2D slice-level using three 2D CNN models for the classification of patients with Alzheimer’s disease (AD) and Parkinson’s disease (PD). Our experiments showed that slice-level CV erroneously boosted the average slice level accuracy on the test set by 30% on Open Access Series of Imaging Studies (OASIS), 29% on Alzheimer’s Disease Neuroimaging Initiative (ADNI), 48% on Parkinson's Progression Markers Initiative (PPMI) and 55% on a local de-novo PD Versilia dataset. Further tests on a randomly labeled OASIS-derived dataset produced about 96% of (erroneous) accuracy (slice-level split) and 50% accuracy (subject-level split), as expected from a randomized experiment. Overall, the extent of the effect of an erroneous slice-based CV is severe, especially for small datasets.

scholarly journals Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021

2021 ◽  
pp. 1-16
Author(s):  
A.P. Porsteinsson ◽  
R.S. Isaacson ◽  
S. Knox ◽  
M.N. Sabbagh ◽  
I. Rubino
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Practice ◽  
Early Stage ◽  
Current Model ◽  
Healthcare Providers ◽  
Disease Diagnosis ◽  
Lifestyle Changes ◽  
Behavioral Impairment ◽  
Alzheimer’S Disease Dementia

Alzheimer’s disease is a progressive, irreversible neurodegenerative disease impacting cognition, function, and behavior. Alzheimer’s disease progresses along a continuum from preclinical disease, to mild cognitive and/or behavioral impairment and then Alzheimer’s disease dementia. Recently, clinicians have been encouraged to diagnose Alzheimer’s earlier, before patients have progressed to Alzheimer’s disease dementia. The early and accurate detection of Alzheimer’s disease-associated symptoms and underlying disease pathology by clinicians is fundamental for the screening, diagnosis, and subsequent management of Alzheimer’s disease patients. It also enables patients and their caregivers to plan for the future and make appropriate lifestyle changes that could help maintain their quality of life for longer. Unfortunately, detecting early-stage Alzheimer’s disease in clinical practice can be challenging and is hindered by several barriers including constraints on clinicians’ time, difficulty accurately diagnosing Alzheimer’s pathology, and that patients and healthcare providers often dismiss symptoms as part of the normal aging process. As the prevalence of this disease continues to grow, the current model for Alzheimer’s disease diagnosis and patient management will need to evolve to integrate care across clinical disciplines and the disease continuum, beginning with primary care. This review summarizes the importance of establishing an early diagnosis of Alzheimer’s disease, related practical ‘how-to’ guidance and considerations, and tools that can be used by healthcare providers throughout the diagnostic journey.

Sign in / Sign up

Export Citation Format

Share Document